Clinical Trial Update: Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 clinical trial evaluating safety, tolerability, and pharmacodynamic effects of a new anti-inflammatory substan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis Vulgaris

Drugs mentioned

• New anti-inflammatory substance

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED